Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol-Myers Squibb Is A Bargain Now
02:27pm, Thursday, 18'th Jul 2024
Bristol-Myers Squibb reported first quarter results and had to lower its guidance for fiscal 2024 due to the IPRD acquisition for $12.9 billion. The company will also lose patent protection for Revlim
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
05:00am, Thursday, 18'th Jul 2024
Bristol Myers Squibb is down big this year, but with a growth strategy in place, it can make for an appealing contrarian investment. AT&T's business is growing, and its strong free cash flow could pav
Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk?
02:00pm, Wednesday, 17'th Jul 2024
Bristol-Myers Squibb continues to underperform the wider market with bullish support yet to materialize, despite the double beat FQ1'24 earnings call, cost-saving strategies, and numerous regulatory w
Bristol-Myers Squibb Reports On 7/26 - Options Expire The Same Day
12:47pm, Wednesday, 17'th Jul 2024
According to NextEarningsDate.com, the Bristol-Myers Squibb next earnings date is projected to be 7/26 before market open, with earnings estimates of $1.53/share on $10.56 Billion of revenue.
Don't Let The Market Fool You: Bristol-Myers Is Not A Value Trap
10:00am, Wednesday, 17'th Jul 2024
Don't Let The Market Fool You: Bristol-Myers Is Not A Value Trap
Trade Tracker: Rob Sechan sells Bristol Myers and buys more Abbvie
01:27pm, Tuesday, 16'th Jul 2024
Rob Sechan, CEO of NewEdge Wealth, joins CNBC's "Halftime Report" to discuss his latest moves. The Committee discuss the Healthcare sector.
Bristol Myers Squibb: The More It Drops, The More I Buy
08:10am, Tuesday, 16'th Jul 2024
Stock market investing is not a zero-sum game, offering long-term potential for growth and income when it comes to highly undervalued stocks. Bristol Myers Squibb stock is undervalued, with strong rev
The Rate Cut Is On: Buy These 6 High-Yield Dividend Stocks Now
07:48am, Tuesday, 16'th Jul 2024
24/7 Insights Traders are betting that the first federal funds rate cut will come in September.
Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever
06:25am, Monday, 15'th Jul 2024
Healthcare and tech are booming, and these businesses are great ways to play each industry. Bristol Myers Squibb is going through a transition period, but the dividend payer has a lot to offer investo
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
08:15am, Saturday, 13'th Jul 2024
Bristol Myers faces multiple challenges, but if it can overcome them, its stock could prove to be a steal of a deal. Cisco's sales haven't gotten a boost yet from AI, but it may only be a matter of ti
2 Pharma Stocks to Buy Hand Over Fist This Month
05:29am, Saturday, 13'th Jul 2024
Pfizer and Bristol Myers have faced issues recently that have led to poor stock market performances. However, both drugmakers are spinning their innovative wheels and look likely to bounce back.
Bristol Myers (BMY) Loses 20.5% YTD: Should You Retain or Fold?
12:36pm, Friday, 12'th Jul 2024
Bristol Myers (BMY) faces an uphill struggle as top drugs face challenges. We advise investors to steer clear for the time being.
5 Under $50 Dividend Stocks to Buy Now
08:45am, Friday, 12'th Jul 2024
24/7 Insights Dividend stocks offer investors the opportunity to increase investment total return.
Bristol Myers Squibb (BMY) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Thursday, 11'th Jul 2024
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $40.75, denoting a -0.9% change from the preceding trading day.
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Thursday, 11'th Jul 2024
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
